Literature DB >> 30526204

Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy.

K B Bukan1,2, A Nardo-Marino1, C Hagdrup3, M Boennelycke4, M F Breinholdt4, C Schöllkopf1, H V Nielsen5, D El Fassi1,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30526204     DOI： 10.1080/03009742.2018.1533035

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  1 in total

1.  Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy.

Authors:  Amina Nardo-Marino; Katrine Bukan; Henrik Vedel Nielsen; Daniel El Fassi
Journal:  Eur J Rheumatol       Date:  2019-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.